QUIET TIME THERAPY CIC

Company Registration Number:
15558325 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2026

Period of accounts

Start date: 1 April 2025

End date: 31 March 2026

QUIET TIME THERAPY CIC

Contents of the Financial Statements

for the Period Ended 31 March 2026

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

QUIET TIME THERAPY CIC

Profit And Loss Account

for the Period Ended 31 March 2026

2026 13 months to 31 March 2025


£
£
Turnover: 26,180 30,472
Cost of sales: 0 ( 437 )
Gross profit(or loss): 26,180 30,035
Distribution costs: ( 958 )
Administrative expenses: ( 9,187 ) ( 8,325 )
Operating profit(or loss): 16,993 20,752
Profit(or loss) before tax: 16,993 20,752
Tax: ( 3,229 ) ( 3,943 )
Profit(or loss) for the financial year: 13,764 16,809

QUIET TIME THERAPY CIC

Balance sheet

As at 31 March 2026

Notes 2026 13 months to 31 March 2025


£
£
Current assets
Debtors: 3 17,680
Cash at bank and in hand: 1 50
Total current assets: 17,681 50
Prepayments and accrued income: 4,739
Net current assets (liabilities): 17,681 4,789
Total assets less current liabilities: 17,681 4,789
Creditors: amounts falling due after more than one year: 4 ( 7,172 ) ( 3,943 )
Accruals and deferred income: ( 2,502 ) ( 834 )
Total net assets (liabilities): 8,007 12
Capital and reserves
Called up share capital: 3 3
Profit and loss account: 8,004 9
Total Shareholders' funds: 8,007 12

The notes form part of these financial statements

QUIET TIME THERAPY CIC

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 25 July 2026
and signed on behalf of the board by:

Name: Ange Ernisse Evans-Lutterodt
Status: Director

The notes form part of these financial statements

QUIET TIME THERAPY CIC

Notes to the Financial Statements

for the Period Ended 31 March 2026

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

QUIET TIME THERAPY CIC

Notes to the Financial Statements

for the Period Ended 31 March 2026

  • 2. Employees

    2026 13 months to 31 March 2025
    Average number of employees during the period 1 1

QUIET TIME THERAPY CIC

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Debtors

2026 13 months to 31 March 2025
£ £
Trade debtors 17,680
Total 17,680

QUIET TIME THERAPY CIC

Notes to the Financial Statements

for the Period Ended 31 March 2026

4. Creditors: amounts falling due after more than one year note

2026 13 months to 31 March 2025
£ £
Other creditors 7,172 3,943
Total 7,172 3,943

COMMUNITY INTEREST ANNUAL REPORT

QUIET TIME THERAPY CIC

Company Number: 15558325 (England and Wales)

Year Ending: 31 March 2026

Company activities and impact

Quiet Time Therapy CIC provides accessible, high-quality mental health support through evidence-based therapies such as CBT, EFT, and integrative approaches. We specialise in working with young adults and individuals from marginalised or underrepresented backgrounds, offering a compassionate and non-judgemental space to explore difficulties such as trauma, anxiety, depression, self-esteem, and identity-based challenges. Alongside one-to-one therapy, we deliver community-focused programmes, workshops, and group support designed to reduce barriers to accessing care. Our impact is seen in enabling clients to improve emotional resilience, build healthier coping strategies, and strengthen their sense of identity and belonging. By offering reduced-rate therapy and targeted community initiatives, we increase accessibility to mental health care for those who may not otherwise be able to access it. Through this work we aim to break cycles of silence, support long-term wellbeing, and empower individuals to thrive personally and socially.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
25 July 2026

And signed on behalf of the board by:
Name: Ange Ernisse Evans-Lutterodt
Status: Director